Leo A. Farmer, M.D.; Decision and Order (May 13, 2013)
Jose G. Zavaleta, M.D.; Decision and Order (May 10, 2013)
Schedules of Controlled Substances: Placement of Lorcaserin Into Schedule IV (May 8, 2013)
Top RX Pharmacy; Decision and Order (May 3, 2013)
Lipomed (April 23, 2013)
Fisher
Clinical Services, Inc. (April 23, 2013)
Research Triangle Institute (April 23, 2013)
Wildlife Laboratories, Inc. (April 23, 2013)
S & B Pharma Inc. (April 23, 2013)
Alltech Associates, Inc. (April 23, 2013)
PCAS-Nanosyn, LLC (April 23, 2013)
Cayman Chemical Company (April 23, 2013)
Rhodes
Technologies (April 19, 2013)
Catalent CTS., Inc. (April 19, 2013)
Almac
Clinical Services, Inc., (ACSI) (April 19, 2013)
GE
Healthcare (April 19, 2013)
Nebraska State Penitentiary (April 19, 2013)
Penick Corporaton (April 19, 2013)
Rhodes Technologies (April 19, 2013)
American Radiolabeled Chemicals, Inc. (April 19, 2013)
Navinta, LLC. (April 19, 2013)
National Center for Natural Products Research-NIDA MProject (April 19, 2013)
Schedules of Controlled Substances: Temporary Placement of Three
Synthetic Cannabinoids Into Schedule I (April 12, 2013)
Schedules of Controlled Substances: Placement of Methylone Into
Schedule I (April 12, 2013)
60-Day Notice - Comments Requested: National Drug Threat Survey; Extension With Change
of a Previously Approved Collection (April 3, 2013)
60-Day Notice - Comments Requested: Import/Export Declaration for List I and List II
Chemicals, DEA Forms 486 and 486A (March 29, 2013)
Gary Alfred Shearer, M.D.; Decision And Order (March 28, 2013)
More
|
